Integration of transcriptomics and metabolomics reveals pathways involved in MDSC supernatant attenuation of TGF-β1-induced myofibroblastic differentiation of mesenchymal stem cells
- 13 September 2022
- journal article
- research article
- Published by Springer Nature in Cell and tissue research
- Vol. 390 (3) , 465-489
Abstract
Overexposure to transforming growth factor b1 (TGF-β1) induces myofibroblastic differentiation of mesenchymal stem cells (MSCs), which could be attenuated by myeloid-derived suppressor cell (MDSC) supernatant. However, the promyofibroblastic effects of TGF-β1 and the antimyofibroblastic effects of MDSC supernatant in MSCs have not been fully elucidated. To further clarify the latent mechanism and identify underlying therapeutic targets, we used an integrative strategy combining transcriptomics and metabolomics. Bone marrow MSCs were collected 24 h following TGF-β1 and MDSC supernatant treatment for RNA sequencing and untargeted metabolomic analysis. The integrated data were then analyzed to identify significant gene-metabolite correlations. Differentially expressed genes (DEGs) and differentially expressed metabolites (DEMs) were assessed by Gene Ontology (GO) functional annotation and Kyoto Encyclopedia of Genes and Genomes (KEGG) pathway analyses for exploring the mechanisms of myofibroblastic differentiation of MSCs. The integration of transcriptomic and metabolomic data highlighted significantly coordinated changes in glycolysis/gluconeogenesis and purine metabolism following TGF-β1 and MDSC supernatant treatment. By combining transcriptomic and metabolomic analyses, this study showed that glycolysis/gluconeogenesis and purine metabolism were essential for the myofibroblastic differentiation of MSCs and may serve as promising targets for mechanistic research and clinical practice in the treatment of fibrosis by MDSC supernatant.Keywords
Funding Information
- Key Technologies Research and Development Program (2018YFA0107501)
- National Natural Science Foundation of China (81770747, 81970646)
This publication has 33 references indexed in Scilit:
- Inhibiting aerobic glycolysis suppresses renal interstitial fibroblast activation and renal fibrosisAmerican Journal of Physiology-Renal Physiology, 2017
- Mesenchymal stem cell‐derived factors: Immuno‐modulatory effects and therapeutic potentialBioFactors, 2017
- The mTOR signal regulates myeloid-derived suppressor cells differentiation and immunosuppressive function in acute kidney injuryCell Death & Disease, 2017
- Glycolytic Reprogramming in Myofibroblast Differentiation and Lung FibrosisAmerican Journal of Respiratory and Critical Care Medicine, 2015
- Differential Induction of Ly6G and Ly6C Positive Myeloid Derived Suppressor Cells in Chronic Kidney and Liver Inflammation and FibrosisPLOS ONE, 2015
- Perivascular Gli1+ Progenitors Are Key Contributors to Injury-Induced Organ FibrosisCell Stem Cell, 2015
- Roles of transforming growth factor‐β1 and OB‐cadherin in porcine cardiac valve myofibroblast differentiationThe FASEB Journal, 2014
- Origin and function of myofibroblasts in kidney fibrosisNature Medicine, 2013
- Hepatitis B Virus X Protein Induces Hepatic Steatosis Via Transcriptional Activation of SREBP1 and PPARγGastroenterology, 2007
- Peroxisome proliferator-activated receptors (PPARs): Nuclear receptors at the crossroads between lipid metabolism and inflammationInflammation Research, 2000